We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.
- Authors
Kantoff, Philip W; Schuetz, Thomas J; Blumenstein, Brent A; Glode, L Michael; Bilhartz, David L; Wyand, Michael; Manson, Kelledy; Panicali, Dennis L; Laus, Reiner; Schlom, Jeffrey; Dahut, William L; Arlen, Philip M; Gulley, James L; Godfrey, Wayne R
- Abstract
Therapeutic prostate-specific antigen (PSA) -targeted poxviral vaccines for prostate cancer have been well tolerated. PROSTVAC-VF treatment was evaluated for safety and for prolongation of progression-free survival (PFS) and overall survival (OS) in a randomized, controlled, and blinded phase II study.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Vol 28, Issue 7, p1099
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2009.25.0597